[
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates",
    "summary": "Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=cf5628029b83c4f3bf6ee731b1e9b48bcf08d84faab4c7761a8c57114cc3721b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752693901,
      "headline": "Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates",
      "id": 135972366,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=cf5628029b83c4f3bf6ee731b1e9b48bcf08d84faab4c7761a8c57114cc3721b"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Surpasses Q2 Earnings and Revenue Estimates",
    "summary": "Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=ab4df90a478d68601da7f57bdc641a6260c222f8c7b4e33e948841d0828c33bd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752693601,
      "headline": "Johnson & Johnson (JNJ) Surpasses Q2 Earnings and Revenue Estimates",
      "id": 135972367,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=ab4df90a478d68601da7f57bdc641a6260c222f8c7b4e33e948841d0828c33bd"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson shrugs off tariff impact and forecasts sales boost",
    "summary": "Johnson & Johnson has shrugged off the impact of tariffs as the US-based healthcare group raised its earnings and sales guidance for 2025. J...",
    "url": "https://finnhub.io/api/news?id=682785971e5c5fd91bbbdc36c049d3f2dd070d4a886b35947d140bf1cc92d0a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752661507,
      "headline": "Johnson & Johnson shrugs off tariff impact and forecasts sales boost",
      "id": 135965004,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Johnson & Johnson has shrugged off the impact of tariffs as the US-based healthcare group raised its earnings and sales guidance for 2025. J...",
      "url": "https://finnhub.io/api/news?id=682785971e5c5fd91bbbdc36c049d3f2dd070d4a886b35947d140bf1cc92d0a8"
    }
  },
  {
    "ts": null,
    "headline": "Trump Threatens Pharma Tariffs Soon. Why the Stocks Are Looking Healthy.",
    "summary": "Trump Threatens Pharma Tariffs Soon. Why the Stocks Are Looking Healthy.",
    "url": "https://finnhub.io/api/news?id=97ab44abf5ee1b1e0d567b77c8e08918c45866d82561979061d15f1dab32bc80",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752669900,
      "headline": "Trump Threatens Pharma Tariffs Soon. Why the Stocks Are Looking Healthy.",
      "id": 135975027,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Trump Threatens Pharma Tariffs Soon. Why the Stocks Are Looking Healthy.",
      "url": "https://finnhub.io/api/news?id=97ab44abf5ee1b1e0d567b77c8e08918c45866d82561979061d15f1dab32bc80"
    }
  },
  {
    "ts": null,
    "headline": "Leading Drug Delivery Conference PODD Announces its 15th Annual Agenda",
    "summary": "Today, PODD: Partnership Opportunities in Drug Delivery – the leading event reporting on key developments in drug delivery technologies – announced the agenda and featured sessions for its 15th annual conference, which will take place on October 27-28 at the Westin Copley Place in Boston, MA.",
    "url": "https://finnhub.io/api/news?id=c65bcd8c51903f1a8a5189ec08d59e1b302390bb394211f3d978609828009681",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752664200,
      "headline": "Leading Drug Delivery Conference PODD Announces its 15th Annual Agenda",
      "id": 135964839,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Today, PODD: Partnership Opportunities in Drug Delivery – the leading event reporting on key developments in drug delivery technologies – announced the agenda and featured sessions for its 15th annual conference, which will take place on October 27-28 at the Westin Copley Place in Boston, MA.",
      "url": "https://finnhub.io/api/news?id=c65bcd8c51903f1a8a5189ec08d59e1b302390bb394211f3d978609828009681"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Q2 Earnings Review: This Is As Safe As Pharma Investing Gets",
    "summary": "Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my JNJ earnings update.",
    "url": "https://finnhub.io/api/news?id=a594a173bc9ecc736739ba1cba4a05096248d9c9d8c7022d549a3275305b6ab9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752663831,
      "headline": "Johnson & Johnson Q2 Earnings Review: This Is As Safe As Pharma Investing Gets",
      "id": 135968725,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1180491673/image_1180491673.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my JNJ earnings update.",
      "url": "https://finnhub.io/api/news?id=a594a173bc9ecc736739ba1cba4a05096248d9c9d8c7022d549a3275305b6ab9"
    }
  },
  {
    "ts": null,
    "headline": "Tariffs Are Showing Up in Inflation. Why Trump Can’t Afford to Ditch Powell.",
    "summary": "House deals a blow to “Crypto Week,” ASML warns on 2026 growth, a promising Chinese weight-loss drug, and more news to start your day.",
    "url": "https://finnhub.io/api/news?id=afcaba7de8f069f51abfb0a2a6b88d86d92d5587baa52dbb9409c5ec4c02070b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752663360,
      "headline": "Tariffs Are Showing Up in Inflation. Why Trump Can’t Afford to Ditch Powell.",
      "id": 135964677,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "House deals a blow to “Crypto Week,” ASML warns on 2026 growth, a promising Chinese weight-loss drug, and more news to start your day.",
      "url": "https://finnhub.io/api/news?id=afcaba7de8f069f51abfb0a2a6b88d86d92d5587baa52dbb9409c5ec4c02070b"
    }
  },
  {
    "ts": null,
    "headline": "Trump Threatens Pharma Tariffs This Month. Why the Stocks Are Looking Healthy.",
    "summary": "Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.",
    "url": "https://finnhub.io/api/news?id=448f593dcc2fcaff7ce0f76ae6948953b4e572c7fe3374e6435eac06eeae5e30",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752662100,
      "headline": "Trump Threatens Pharma Tariffs This Month. Why the Stocks Are Looking Healthy.",
      "id": 135964841,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.",
      "url": "https://finnhub.io/api/news?id=448f593dcc2fcaff7ce0f76ae6948953b4e572c7fe3374e6435eac06eeae5e30"
    }
  },
  {
    "ts": null,
    "headline": "FDA invites more data from abroad — with a wary eye on China",
    "summary": "The FDA approved four drugs last year without any U.S. trial participants, but has maintained a tougher stance on China, even as it grows into an R&D powerhouse.",
    "url": "https://finnhub.io/api/news?id=d8dfa832c32e7b1e0c8388a51b7283b654bb1e34cabdefc84fd48ca7ca6992c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752652800,
      "headline": "FDA invites more data from abroad — with a wary eye on China",
      "id": 135972372,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The FDA approved four drugs last year without any U.S. trial participants, but has maintained a tougher stance on China, even as it grows into an R&D powerhouse.",
      "url": "https://finnhub.io/api/news?id=d8dfa832c32e7b1e0c8388a51b7283b654bb1e34cabdefc84fd48ca7ca6992c9"
    }
  },
  {
    "ts": null,
    "headline": "Many US employers plan to pare health benefits as weight-loss spending soars",
    "summary": "More than half of largeU.S. employers plan to scale back healthcare benefits next yearas rising costs from weight-loss and specialty drugs squeezebudgets, according to a new survey released by...",
    "url": "https://finnhub.io/api/news?id=13cba3bd9fb4c389bf27f388bfe2b7491b6b2ec4948fbe3cbfc02db47d29b54c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752645742,
      "headline": "Many US employers plan to pare health benefits as weight-loss spending soars",
      "id": 135963469,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "More than half of largeU.S. employers plan to scale back healthcare benefits next yearas rising costs from weight-loss and specialty drugs squeezebudgets, according to a new survey released by...",
      "url": "https://finnhub.io/api/news?id=13cba3bd9fb4c389bf27f388bfe2b7491b6b2ec4948fbe3cbfc02db47d29b54c"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on Eli Lilly: “How Can You Leave This One Right Here?”",
    "summary": "Eli Lilly and Company (NYSE:LLY) is one of the stocks in Jim Cramer’s spotlight. Answering a caller’s query about the company, Cramer said: “Alright, listen to me. This one is one that everyone’s going to give up on. Then one day, it’s going to be up 300, I’m not kidding. That’s what happens with these […]",
    "url": "https://finnhub.io/api/news?id=3602ed465f539998fd70b18fc87595450b913bc899d1bb89bc7955ec15bd43b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752638558,
      "headline": "Jim Cramer on Eli Lilly: “How Can You Leave This One Right Here?”",
      "id": 135964842,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly and Company (NYSE:LLY) is one of the stocks in Jim Cramer’s spotlight. Answering a caller’s query about the company, Cramer said: “Alright, listen to me. This one is one that everyone’s going to give up on. Then one day, it’s going to be up 300, I’m not kidding. That’s what happens with these […]",
      "url": "https://finnhub.io/api/news?id=3602ed465f539998fd70b18fc87595450b913bc899d1bb89bc7955ec15bd43b6"
    }
  }
]